<p>Cell viability was assessed via the CCK-8 method. HUVECs were exposed to different concentrations of resveratrol (0, 5, 10, and 20 μM) before treatment with TNF-α (10 μg/L). Data are expressed as the mean ± SEM from six independent experiments, each carried out in triplicate. *<i>p</i> < 0.05 vs. control; #<i>p</i> < 0.05 vs. TNF-α alone.</p
<p>MCF-7 (A), H1299 (B), A549 (C), and H460 cells (D) were treated with various concentrations of <i...
<p>(<b>a</b>) The proliferation of CD4<sup>+</sup> T cells treated with different concentrations of ...
<p>(A) p53-transfected and non-transfected H1299 cells were treated with resveratrol (100 µM). The c...
<p><b>A.</b> 3T3/NIH cells were pretreated 1 h with varying concentrations of resveratrol (Res) befo...
<p>Differentiated DC were stimulated with TNF-α, in presence or absence of resveratrol as indicated,...
<p>RAW 264.7 cells were treated with 1, 5, and 10 µM of resveratrol without LPS treatments or with 5...
<p>Cells were pre-treated for 1 h in the presence of 100 µM resveratrol (RSV) followed by the additi...
<p>(A) Huh7 cells were treated with resveratrol (0, 25, 50, 75, 100 and 200 µM) for 24 h and 48 h be...
<p><b>(A)</b> HUVECs were either transfected with specific siRNA against SIRT1, Nc-siRNA (scrambled ...
<p>MTS assay was performed on PC-3M-MM2 cells treated with vehicle or different concentrations of re...
<p><b>(A)</b> HUVECs were treated with different concentrations of resveratrol (0, 5, 10, and 20 μM)...
<p>Differentiated DC were stimulated as indicated, with LPS or TNF-α, in presence or absence of resv...
<p>HUVECs were pretreated with 10 μM resveratrol in the presence or absence of Ex527 before TNF-α st...
Objective: Resveratrol, a safe and multitargeted natural agent, has been linked with inhibition of s...
<p>(A–C) HepG2 (A), Hep3B (B) and HuH7 (C) hepatoma tumor cells were treated with different concentr...
<p>MCF-7 (A), H1299 (B), A549 (C), and H460 cells (D) were treated with various concentrations of <i...
<p>(<b>a</b>) The proliferation of CD4<sup>+</sup> T cells treated with different concentrations of ...
<p>(A) p53-transfected and non-transfected H1299 cells were treated with resveratrol (100 µM). The c...
<p><b>A.</b> 3T3/NIH cells were pretreated 1 h with varying concentrations of resveratrol (Res) befo...
<p>Differentiated DC were stimulated with TNF-α, in presence or absence of resveratrol as indicated,...
<p>RAW 264.7 cells were treated with 1, 5, and 10 µM of resveratrol without LPS treatments or with 5...
<p>Cells were pre-treated for 1 h in the presence of 100 µM resveratrol (RSV) followed by the additi...
<p>(A) Huh7 cells were treated with resveratrol (0, 25, 50, 75, 100 and 200 µM) for 24 h and 48 h be...
<p><b>(A)</b> HUVECs were either transfected with specific siRNA against SIRT1, Nc-siRNA (scrambled ...
<p>MTS assay was performed on PC-3M-MM2 cells treated with vehicle or different concentrations of re...
<p><b>(A)</b> HUVECs were treated with different concentrations of resveratrol (0, 5, 10, and 20 μM)...
<p>Differentiated DC were stimulated as indicated, with LPS or TNF-α, in presence or absence of resv...
<p>HUVECs were pretreated with 10 μM resveratrol in the presence or absence of Ex527 before TNF-α st...
Objective: Resveratrol, a safe and multitargeted natural agent, has been linked with inhibition of s...
<p>(A–C) HepG2 (A), Hep3B (B) and HuH7 (C) hepatoma tumor cells were treated with different concentr...
<p>MCF-7 (A), H1299 (B), A549 (C), and H460 cells (D) were treated with various concentrations of <i...
<p>(<b>a</b>) The proliferation of CD4<sup>+</sup> T cells treated with different concentrations of ...
<p>(A) p53-transfected and non-transfected H1299 cells were treated with resveratrol (100 µM). The c...